0001209191-19-047993.txt : 20190903
0001209191-19-047993.hdr.sgml : 20190903
20190903164918
ACCESSION NUMBER: 0001209191-19-047993
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190830
FILED AS OF DATE: 20190903
DATE AS OF CHANGE: 20190903
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CALSADA CRISPINA
CENTRAL INDEX KEY: 0001606833
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35670
FILM NUMBER: 191072532
MAIL ADDRESS:
STREET 1: C/O AMBRX, INC.
STREET 2: 10975 N. TORREY PINES RD.
CITY: LA JOLLA
STATE: CA
ZIP: 92037
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Regulus Therapeutics Inc.
CENTRAL INDEX KEY: 0001505512
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 264738379
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10628 SCIENCE CENTER DRIVE
STREET 2: SUITE 225
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-202-6300
MAIL ADDRESS:
STREET 1: 10628 SCIENCE CENTER DRIVE
STREET 2: SUITE 225
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-08-30
0
0001505512
Regulus Therapeutics Inc.
RGLS
0001606833
CALSADA CRISPINA
C/O REGULUS THERAPEUTICS
10628 SCIENCE CENTER DR. #225
SAN DIEGO
CA
92121
0
1
0
0
Chief Financial Officer
Stock Option (Right to Buy)
0.62
2019-08-30
4
A
0
100000
0.00
A
2029-08-29
Common Stock
100000
100000
D
Twenty-Five percent of the options will vest on the one year anniversary date of the grant and the balance of the shares will vest in a series of thirty-six equal monthly installments thereafter, such that the option is fully vested on the fourth anniversary of the date of grant.
Christopher Aker, Attorney in Fact
2019-09-03